Following Bio-IT World, we’re asking some of the world’s top researchers how next generation sequencing (NGS) benefits them and their work. Today, we catch up with Mayo Clinic expert David I Smith, Ph. D, who says NGS allows him to ask and answer questions in a surprisingly short amount of time. The real value, he points out, is that sequencing gives researchers the ability to look at trillions of molecules to see what is happening to populations and move research discoveries, particularly in cancer, forward.
Watch the above video to learn more and discover how cancer treatments will be dramatically different five years from now, and what keeps Smith up at night when it comes to NGS.